Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,116 | 198 | 83.4% |
| Consulting Fee | $450.00 | 3 | 12.0% |
| Education | $171.61 | 6 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $582.25 | 50 | $0 (2019) |
| COMSORT, Inc | $450.00 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $284.36 | 20 | $0 (2021) |
| Amgen Inc. | $263.02 | 15 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $231.04 | 11 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $193.88 | 14 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $189.05 | 13 | $0 (2019) |
| Lilly USA, LLC | $173.44 | 12 | $0 (2019) |
| Incyte Corporation | $163.76 | 2 | $0 (2022) |
| Celgene Corporation | $120.54 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $228.95 | 3 | GlaxoSmithKline, LLC. ($86.25) |
| 2021 | $102.34 | 7 | Gilead Sciences, Inc. ($25.44) |
| 2020 | $92.67 | 6 | Seagen Inc. ($35.90) |
| 2019 | $535.88 | 31 | Taiho Oncology, Inc. ($62.39) |
| 2018 | $1,134 | 69 | Genentech USA, Inc. ($208.77) |
| 2017 | $1,643 | 91 | Genentech USA, Inc. ($329.45) |
All Payment Transactions
207 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $86.25 | General |
| Category: ONCOLOGY | ||||||
| 07/07/2022 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $63.81 | General |
| Category: Oncology | ||||||
| 06/09/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $78.89 | General |
| Category: Oncology | ||||||
| 08/18/2021 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Oncology | ||||||
| 06/30/2021 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: ONC | ||||||
| 06/28/2021 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Oncology | ||||||
| 06/02/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 02/03/2021 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug), IDHIFA | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Oncology | ||||||
| 01/19/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Oncology | ||||||
| 05/16/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Oncology | ||||||
| 05/13/2020 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Oncology | ||||||
| 02/12/2020 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Oncology | ||||||
| 01/29/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Oncology | ||||||
| 01/28/2020 | EMD Serono, Inc. | Bavencio (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Oncology | ||||||
| 01/09/2020 | CSL Behring | Afstyla (Biological) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Hematology | ||||||
| 11/05/2019 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, TECENTRIQ | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: BioOncology | ||||||
| 11/04/2019 | Taiho Oncology, Inc. | Lonsurf (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Oncology | ||||||
| 10/30/2019 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Immunology | ||||||
| 10/16/2019 | Lilly USA, LLC | ALIMTA (Drug), CYRAMZA, VERZENIO | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Oncology | ||||||
| 09/18/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.22 | General |
| Category: Oncology | ||||||
| 09/10/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ONCOLOGY | ||||||
| 06/24/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Oncology | ||||||
| 06/20/2019 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Immunology | ||||||
| 06/12/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Hematology / Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 27 | 44 | $7,537 | $2,336 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 27 | 44 | $7,537 | $2,336 | 31.0% |
About Dr. Edward Smith, M.D
Dr. Edward Smith, M.D is a Specialist healthcare provider based in St. Ignace, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174542781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Smith, M.D has received a total of $3,738 in payments from pharmaceutical and medical device companies, with $228.95 received in 2022. These payments were reported across 207 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,116).
As a Medicare-enrolled provider, Smith has provided services to 27 Medicare beneficiaries, totaling 44 services with total Medicare billing of $2,336. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location St. Ignace, MI
- Active Since 07/18/2006
- Last Updated 11/18/2016
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1174542781
Products in Payments
- KEYTRUDA (Biological) $517.95
- OPDIVO (Biological) $220.34
- Perjeta (Biological) $194.70
- Neulasta (Biological) $174.98
- EKOSONIC (Device) $112.50
- ADCETRIS (Biological) $107.17
- ZEJULA (Drug) $103.81
- TAGRISSO (Drug) $101.89
- Lonsurf (Drug) $97.39
- Avastin (Biological) $96.64
- CYRAMZA (Drug) $92.69
- TECENTRIQ (Biological) $92.53
- GAZYVA (Biological) $77.86
- FASLODEX (Drug) $76.88
- Alecensa (Biological) $76.59
- ALIMTA (Drug) $64.85
- MEKINIST (Drug) $63.96
- MONJUVI (Drug) $63.81
- Kyprolis (Biological) $51.08
- AFINITOR (Drug) $50.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.